Filing Flows

Filing Flows › Industries › Health Care › Services-Misc Health & Allied Services, NEC

Services-Misc Health & Allied Services, NEC SIC 8090

10 companies filing with the SEC under SIC 8090. Median revenue growth +5% year on year in Q3 2026 (middle half +2% to +7%, 7 companies). The growth model expects the industry's combined revenue to grow +7% in Q3 2026. 2 customer or supplier links named in annual reports.

Companies10
Median growth Y/Y+5%
Middle half+2% to +7%
Industry revenue, next quarter+7% Y/Y (Q3 2026, model)
Services-Misc Health & Allied Services, NEC: the largest companies by quarterly revenueServices-Misc Health & Allied Services, NEC: the largest companies by quarterly revenueDVA$3.6BAGL$1.5BPGNY$341MSHC$325MVMD$80.7MPARK$66.2MCCEL$7.8MMRAI$4.2MPFHO$1.5MMGRX$69K
Services-Misc Health & Allied Services, NEC: how many companies grew how fast (revenue, year over year)Services-Misc Health & Allied Services, NEC: how many companies grew how fast (revenue, year over year)0< −25%0−25 to −10%2−10 to 0%40 to 10%110 to 25%025 to 50%0> 50%
Services-Misc Health & Allied Services, NEC: the growth model's forecast of industry revenueServices-Misc Health & Allied Services, NEC: the growth model's forecast of industry revenue80% rangemodel's central forecastQ3 2026$5.9BQ4 2026$6.3BQ1 2027$5.9BQ2 2027$6.2B

Money flow: where the industry's revenue goes

Drawn in the browser: an estimate of where the industry's revenue goes — what it buys from other industries, the pay that reaches households, taxes and profit — beside its filed cash flow, two tiers of suppliers and its capital spending by kind of asset.

Open the industry: growth distribution, money flow, network →

Who sells to whom

Customers and suppliers named in the companies' annual reports; the share is of the supplier's revenue.

Growth model

Industry revenue, the same companies year on year; 80% ranges. Fitted on SEC filings and tested out of sample (how).

QuarterGrowth Y/YRevenue80% range
Q3 2026+6.7%$5.9B$5.6B – $6.3B
Q4 2026+7.2%$6.3B$5.9B – $6.7B
Q1 2027+7.4%$5.9B$5.5B – $6.4B
Q2 2027+7.4%$6.2B$5.8B – $6.7B

Capital spending and supply chain →

Companies

CompanyQuarterly revenueY/YStage
DVA Davita$3.6B+5%mature
AGL agilon health$1.5B+6%mature
PGNY Progyny$341M+9%mature
SHC Sotera Health$325M+4%deceleration
VMD Viemed Healthcare$80.7M+12%deceleration
PARK Park Dental Partners$66.2M—mature
CCEL Cryo Cell International$7.8M0%mature
MRAI Marpai$4.2M—transition
PFHO Pacific Health Care Organization$1.5M-5%mature
MGRX Mangoceuticals$69K—contraction

Growth from positive, comparable quarterly revenue as filed; industries are SEC Standard Industrial Classification codes. Data Nov 8, 2026.